Target intelligence / Profile preview

Systemic iron metabolism

Molecular classification
Pathway, Biological process, Peptide hormone (Hepcidin), Transporter (Ferroportin, DMT1), Receptor (Transferrin receptor)
01

Overview

Systemic iron metabolism is the highly regulated physiological process responsible for maintaining iron homeostasis by balancing iron absorption, transport, storage, and recycling. The system is primarily controlled by the hepatic hormone hepcidin, which acts as a master regulator by binding to and inducing the degradation of ferroportin, the only known cellular iron exporter. This interaction determines the amount of iron released into the plasma from duodenal enterocytes, recycling macrophages, and storage hepatocytes. Iron is a critical cofactor for hemoglobin-mediated oxygen transport, mitochondrial energy production, and DNA synthesis; however, its ability to participate in Fenton chemistry means that excess free iron can lead to significant oxidative damage. Dysregulation of this system is central to the pathogenesis of various disorders, including iron deficiency anemia, hereditary hemochromatosis, and anemia of inflammation. Therapeutic strategies targeting this system include iron chelators to remove excess iron, hepcidin modulators to treat iron-restricted anemias or overload, and direct iron supplementation to replenish depleted stores.

Other names
Iron homeostasisSystemic iron regulationHepcidin-ferroportin axisIron metabolism
02

Mechanism of action

Modulation of iron levels through chelation of excess iron, supplementation of elemental iron, or pharmacological regulation of the hepcidin-ferroportin axis to control iron absorption and recycling.

03

Biological functions

Oxygen transportDNA synthesisCellular respirationIron storageIron recyclingNutritional immunity
04

Disease associations

Iron deficiency anemiaAnemia of chronic diseaseHereditary hemochromatosisCancerNeurodegenerative diseaseChronic kidney disease
05

Safety considerations

Iron overload-induced oxidative stress and organ damageGastrointestinal toxicity from oral iron supplementsHypersensitivity and anaphylaxis from intravenous ironIncreased risk of infection due to enhanced bacterial access to free iron
06

Interacting drugs

Deferoxamine

7 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Soluble transferrin receptor (sTfR)Serum hepcidinHemoglobinReticulocyte hemoglobin equivalent (Ret-He)

Beyond the preview

Go deeper on Systemic iron metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic iron metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call